BioMartin joined Gimv in 2015. Since then he was involved in the investment in Breath Therapeutics and the acquisition of WEMAS Absperrtechnik. Prior to joining Gimv, he gained experience at Adcuram Group (Private Equity), Baader Bank (Equity Capital Markets) and Premier Marketing Group (Project Management).Martin graduated in Business Administration from Fresenius University in Munich and earned a MSc in Finance and Ma ....
Education